Jyrki Pekka Sakari Mattila
No más puestos en curso
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Kai E. Lindevall | M | 72 |
Encorium Group, Inc.
Encorium Group, Inc. Miscellaneous Commercial ServicesCommercial Services Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania. | 18 años |
Paul R. Nemeth | M | - |
iCeutica, Inc.
iCeutica, Inc. Pharmaceuticals: MajorHealth Technology iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA. | 13 años |
Jeremy Fletcher | M | 70 |
iCeutica, Inc.
iCeutica, Inc. Pharmaceuticals: MajorHealth Technology iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA. | 13 años |
Nathan Burkey | M | 50 |
iCeutica, Inc.
iCeutica, Inc. Pharmaceuticals: MajorHealth Technology iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA. | 13 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Thomas L. Wegman | M | 69 | 25 años | |
Rolf Classon | M | 79 | 10 años | |
Armando Anido | M | 66 | 5 años | |
Michael Celano | M | 65 | 3 años | |
Markku Huhta-Koivisto | M | 68 |
Orion Pharma Oy
Orion Pharma Oy Pharmaceuticals: MajorHealth Technology Orion Pharma Oy provides contract manufacturing services to the pharmaceutical sector. Its services include sterile, solid forms, liquid forms, semi-solid forms, hormone, and anti-cancer production, primary as well as secondary packaging, and testing. The company is headquartered in Espoo, Finland. | 10 años |
Shahab Fatheazam | M | 72 |
Encorium Group, Inc.
Encorium Group, Inc. Miscellaneous Commercial ServicesCommercial Services Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania. | - |
Jennifer Chao | F | 54 | 5 años | |
Williams James | M | 54 |
iCeutica, Inc.
iCeutica, Inc. Pharmaceuticals: MajorHealth Technology iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA. | 5 años |
Lawrence R. Hoffman | M | 69 |
Encorium Group, Inc.
Encorium Group, Inc. Miscellaneous Commercial ServicesCommercial Services Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania. | 4 años |
Henri Juhani Huttunen | M | - |
Hermo Pharma Oy
Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently untreatable medical needs, particularly in the field of neurology. The company's R&D programs are based on scientifically innovative concepts. These concepts are being developed through preclinical and early clinical development phases with the aim gaining partners prior to late clinical development phases and finally marketing. The company was founded in 2008 by professors Mart Saarma, Eero Castrén, Heikki Rauvala and Dr. Henri Huttunen. The company operates in close collaboration with several academic laboratories affiliated with the University of Helsinki. Hermo Pharma Ltd. operates according to the 'virtual business model'. This means the company outsources the majority of business functions outside of its core business areas, while controlling the key technology assets and strategic partnerships with a small but highly capable group of people managing operations. As the company's overheads are kept lower than traditional biopharmaceutical companies much more of its financial resources can be utilized directly to achieve business goals. Hermo Pharma Ltd. is a privately owned, venture capital backed company. Its current investors include Helsinki University Funds and Seed Fund Vera Ltd. | 6 años |
Gerri Henwood | F | 71 | 7 años | |
Jennifer Stacey | F | 59 | 7 años | |
James Fickenscher | M | 60 | 9 años | |
Diane Myers | F | 60 | 19 años | |
Robert S. Whitehead | M | 74 | 1 años | |
Pekka Allan Antero Mattila | M | 65 |
Hermo Pharma Oy
Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently untreatable medical needs, particularly in the field of neurology. The company's R&D programs are based on scientifically innovative concepts. These concepts are being developed through preclinical and early clinical development phases with the aim gaining partners prior to late clinical development phases and finally marketing. The company was founded in 2008 by professors Mart Saarma, Eero Castrén, Heikki Rauvala and Dr. Henri Huttunen. The company operates in close collaboration with several academic laboratories affiliated with the University of Helsinki. Hermo Pharma Ltd. operates according to the 'virtual business model'. This means the company outsources the majority of business functions outside of its core business areas, while controlling the key technology assets and strategic partnerships with a small but highly capable group of people managing operations. As the company's overheads are kept lower than traditional biopharmaceutical companies much more of its financial resources can be utilized directly to achieve business goals. Hermo Pharma Ltd. is a privately owned, venture capital backed company. Its current investors include Helsinki University Funds and Seed Fund Vera Ltd. | 1 años |
William Q. Sargent | M | - | - | |
Edwin A. Bescherer | M | 90 | 11 años | |
Laura Offutt | M | - | - | |
Al Altomari | M | 65 | - | |
Arnaud Ajdler | M | 48 | 1 años | |
Kenneth A. Borow | M | 76 |
Encorium Group, Inc.
Encorium Group, Inc. Miscellaneous Commercial ServicesCommercial Services Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania. | 11 años |
David Morra | M | 68 |
Encorium Group, Inc.
Encorium Group, Inc. Miscellaneous Commercial ServicesCommercial Services Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania. | - |
Oliver Fetzer | M | 60 | 10 años | |
Ari-Pekka Laitsaari | M | - |
Hermo Pharma Oy
Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently untreatable medical needs, particularly in the field of neurology. The company's R&D programs are based on scientifically innovative concepts. These concepts are being developed through preclinical and early clinical development phases with the aim gaining partners prior to late clinical development phases and finally marketing. The company was founded in 2008 by professors Mart Saarma, Eero Castrén, Heikki Rauvala and Dr. Henri Huttunen. The company operates in close collaboration with several academic laboratories affiliated with the University of Helsinki. Hermo Pharma Ltd. operates according to the 'virtual business model'. This means the company outsources the majority of business functions outside of its core business areas, while controlling the key technology assets and strategic partnerships with a small but highly capable group of people managing operations. As the company's overheads are kept lower than traditional biopharmaceutical companies much more of its financial resources can be utilized directly to achieve business goals. Hermo Pharma Ltd. is a privately owned, venture capital backed company. Its current investors include Helsinki University Funds and Seed Fund Vera Ltd. | 4 años |
John Harlow | M | - | 3 años | |
McCall Liddy | F | - |
iCeutica, Inc.
iCeutica, Inc. Pharmaceuticals: MajorHealth Technology iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA. | 6 años |
Juhani Anttila | M | 70 |
University of Helsinki
| 6 años |
William McKee | M | 62 | 6 años | |
Scott Wilhoit | M | 61 | - | |
Jian Yi Zhang | M | 67 |
University of Helsinki
| 5 años |
George M. Gould | M | 86 | 6 años | |
Ronald Law | M | 71 | 2 años | |
Martti Sakari Vaara | M | - |
University of Helsinki
| 6 años |
Renato Fuchs | M | 80 | - | |
Esko Tapani Aho | M | 70 |
University of Helsinki
| 1 años |
Anne Marja Riekki | F | - |
Aalto University School of Business
| 4 años |
Risto Rautakorpi | M | - |
Aalto University School of Business
| 1 años |
Eeva-Kaarina Koskelo | M | 65 |
University of Helsinki
| 1 años |
Jarmo Tapio Tonteri | M | 72 |
University of Helsinki
| 1 años |
Eija Pitkänen | F | 63 |
University of Helsinki
| 6 años |
Rainer Henrik Häggblom | M | 68 |
University of Helsinki
| 1 años |
George Cox | M | 73 | 1 años | |
Jillian Dilmore | F | - | 2 años | |
Laura Kristina Kolbe | M | 67 |
University of Helsinki
| 2 años |
Thomas Knut Johannes Wilhelmsson | M | 75 |
University of Helsinki
| 3 años |
Stewart Mccallum | M | 58 | 4 años | |
James R. Englund | M | - | 10 años | |
Suzanne M. Hanlon | F | 67 | 5 años | |
Michael Riebe | M | 63 |
iCeutica, Inc.
iCeutica, Inc. Pharmaceuticals: MajorHealth Technology iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA. | - |
Tiina Marjukka Tuomela | F | 58 |
Aalto University School of Business
| 2 años |
Donna M. Nichols | F | 68 | 5 años | |
Mikko Kuokkanen | M | - |
Hermo Pharma Oy
Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently untreatable medical needs, particularly in the field of neurology. The company's R&D programs are based on scientifically innovative concepts. These concepts are being developed through preclinical and early clinical development phases with the aim gaining partners prior to late clinical development phases and finally marketing. The company was founded in 2008 by professors Mart Saarma, Eero Castrén, Heikki Rauvala and Dr. Henri Huttunen. The company operates in close collaboration with several academic laboratories affiliated with the University of Helsinki. Hermo Pharma Ltd. operates according to the 'virtual business model'. This means the company outsources the majority of business functions outside of its core business areas, while controlling the key technology assets and strategic partnerships with a small but highly capable group of people managing operations. As the company's overheads are kept lower than traditional biopharmaceutical companies much more of its financial resources can be utilized directly to achieve business goals. Hermo Pharma Ltd. is a privately owned, venture capital backed company. Its current investors include Helsinki University Funds and Seed Fund Vera Ltd. | - |
Jarmo Erik Ellonen | M | 68 |
University of Helsinki
| 3 años |
Tapani Voionmaa | M | 73 |
University of Helsinki
| 3 años |
James Tursi | M | 59 | 6 años | |
Antti Urvas | M | - |
Aalto University School of Business
| 4 años |
Timo Ilari Veromaa | M | 64 |
Hermo Pharma Oy
Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently untreatable medical needs, particularly in the field of neurology. The company's R&D programs are based on scientifically innovative concepts. These concepts are being developed through preclinical and early clinical development phases with the aim gaining partners prior to late clinical development phases and finally marketing. The company was founded in 2008 by professors Mart Saarma, Eero Castrén, Heikki Rauvala and Dr. Henri Huttunen. The company operates in close collaboration with several academic laboratories affiliated with the University of Helsinki. Hermo Pharma Ltd. operates according to the 'virtual business model'. This means the company outsources the majority of business functions outside of its core business areas, while controlling the key technology assets and strategic partnerships with a small but highly capable group of people managing operations. As the company's overheads are kept lower than traditional biopharmaceutical companies much more of its financial resources can be utilized directly to achieve business goals. Hermo Pharma Ltd. is a privately owned, venture capital backed company. Its current investors include Helsinki University Funds and Seed Fund Vera Ltd. | 2 años |
Kimmo Pekka Korpela | M | 57 |
Aalto University School of Business
| 6 años |
Timo Ihamuotila | M | 58 |
Aalto University School of Business
| 1 años |
Martha Manning | F | 69 |
iCeutica, Inc.
iCeutica, Inc. Pharmaceuticals: MajorHealth Technology iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA. | 3 años |
Cornelius H. Lansing | M | - | - | |
Mikko Tapio Mursula | M | 58 |
Aalto University School of Business
| 4 años |
Henrik Ehrnrooth | M | 70 |
University of Helsinki
| 1 años |
Klaus Thomas Cawén | M | 67 |
University of Helsinki
| 3 años |
Jari Ilmari Karlson | M | 63 |
Orion Pharma Oy
Orion Pharma Oy Pharmaceuticals: MajorHealth Technology Orion Pharma Oy provides contract manufacturing services to the pharmaceutical sector. Its services include sterile, solid forms, liquid forms, semi-solid forms, hormone, and anti-cancer production, primary as well as secondary packaging, and testing. The company is headquartered in Espoo, Finland. | 1 años |
Ilkka Seppo Salonen | M | 68 |
University of Helsinki
| 1 años |
Kimmo Laaksonen | M | 61 |
Aalto University School of Business
| 1 años |
Paul J. Schmitt | M | 73 |
Encorium Group, Inc.
Encorium Group, Inc. Miscellaneous Commercial ServicesCommercial Services Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania. | 1 años |
Philippe Chambon | M | 65 | 8 años | |
Michael A. Wall | M | 95 | - | |
Jennifer Lou Armstrong-Owen | F | 54 | 6 años | |
Anthony DelConte | M | 66 | 2 años | |
Roger D. Graham | M | 61 | 4 años | |
John H. Dillon | M | 82 | - | |
Dennis Langer | M | 73 | 3 años | |
Terri Sebree | F | 66 | 5 años | |
Keijo A. Väkiparta | M | - |
University of Helsinki
| 1 años |
Jukka Jalmari Pekkarinen | M | 77 |
University of Helsinki
| 3 años |
Frederick H. Graff | M | - | 2 años | |
Tom Henrik Berglund | M | 76 |
University of Helsinki
| 4 años |
Nancy Fetrow | F | - | - | |
Leena Maria Saarinen | F | 64 |
University of Helsinki
| 7 años |
Jaakko Uotila | M | 75 |
University of Helsinki
| 1 años |
Kevin Gunter | M | 63 | - | |
Saila Miettinen-Lähde | F | 62 |
Orion Pharma Oy
Orion Pharma Oy Pharmaceuticals: MajorHealth Technology Orion Pharma Oy provides contract manufacturing services to the pharmaceutical sector. Its services include sterile, solid forms, liquid forms, semi-solid forms, hormone, and anti-cancer production, primary as well as secondary packaging, and testing. The company is headquartered in Espoo, Finland. | - |
Veli-Matti Reinikkala | M | 67 |
Aalto University School of Business
| 2 años |
Veli-Pekka Karvinen | M | - |
University of Helsinki
| 1 años |
Juha Matti Vapaavuori | M | 72 |
University of Helsinki
| 1 años |
Eino Moilanen | M | - |
Orion Pharma Oy
Orion Pharma Oy Pharmaceuticals: MajorHealth Technology Orion Pharma Oy provides contract manufacturing services to the pharmaceutical sector. Its services include sterile, solid forms, liquid forms, semi-solid forms, hormone, and anti-cancer production, primary as well as secondary packaging, and testing. The company is headquartered in Espoo, Finland. | 2 años |
Mart Saarma | M | - |
Hermo Pharma Oy
Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently untreatable medical needs, particularly in the field of neurology. The company's R&D programs are based on scientifically innovative concepts. These concepts are being developed through preclinical and early clinical development phases with the aim gaining partners prior to late clinical development phases and finally marketing. The company was founded in 2008 by professors Mart Saarma, Eero Castrén, Heikki Rauvala and Dr. Henri Huttunen. The company operates in close collaboration with several academic laboratories affiliated with the University of Helsinki. Hermo Pharma Ltd. operates according to the 'virtual business model'. This means the company outsources the majority of business functions outside of its core business areas, while controlling the key technology assets and strategic partnerships with a small but highly capable group of people managing operations. As the company's overheads are kept lower than traditional biopharmaceutical companies much more of its financial resources can be utilized directly to achieve business goals. Hermo Pharma Ltd. is a privately owned, venture capital backed company. Its current investors include Helsinki University Funds and Seed Fund Vera Ltd. | 1 años |
Edward F. Kessig | M | - | 8 años | |
Ritchie Deffenbaugh | M | - | - | |
Benjamin J. del Tito | M | 68 | - | |
Stewart Washer | M | 54 |
iCeutica, Inc.
iCeutica, Inc. Pharmaceuticals: MajorHealth Technology iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA. | 1 años |
Fredrik Urvas Antti | M | - |
Aalto University School of Business
| 4 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 58 | 58.00% |
Finlandia | 42 | 42.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones